Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-12

Clinical Trial Update: Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating regular U-500 insulin in adults with type 2 diabetes has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humulin R U-500 (insulin regular (human))

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2015-05-12